3Dvorakovd K,Dorr R T,Vacie S,et al.Pharmacokinetics of the green tea derivative,EGCG,by the topical route of administration inmouseand humanskin[J],Cancer Chem other Pharmacol,1999,43:331-335.
4Liao,Shutsang,Liang.Methods and compositions for inhibitin g 5α reductaseactivity[P].United States Patent:605929.1997 05.
5王泽农等.茶叶生物化学北京农业出版 1984.6
6Daniel A. Effect of a hypocaloric diet on serum visfatin inobese non-diabetic patients [J].Nutrition. 2013,24(6):517-521.